Canton Strategic Holdings (CNTN) EBIT (2021 - 2026)
Canton Strategic Holdings (CNTN) reported EBIT of -$36.9 million for Q1 2026, down 1347.71% on a YoY basis from $3.0 million in Q1 2025, and down 1474.42% quarter-over-quarter from -$2.3 million in Q4 2025.
Canton Strategic Holdings (CNTN) EBIT (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported EBIT for 6 years, with the latest figure at -$36.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 1347.71% year-over-year to -$36.9 million; the trailing twelve-month figure through Mar 2026 stood at -$43.2 million (down 242.52% YoY), and the FY2025 full-year result was -$8.8 million, up 28.7% from the prior year.
- EBIT for Q1 2026 stood at -$36.9 million, down from -$2.3 million in the prior quarter.
- The five-year high for EBIT was -$1.4 million in Q1 2022, with the low at -$36.9 million in Q1 2026.
- Historically, EBIT has averaged -$4.4 million across 5 years, with a median of -$2.3 million in 2024.
- Annual changes were most pronounced in 2022 — EBIT slumped 1638.74% — and 2025, when it jumped 45.84%.
- Canton Strategic Holdings' EBIT stood at -$1.8 million in 2022, then plunged by 43.29% to -$2.5 million in 2023, then slumped by 50.67% to -$3.8 million in 2024, then jumped by 38.6% to -$2.3 million in 2025, then sank by 1474.42% to -$36.9 million in 2026.
- The last three EBIT figures came in at -$36.9 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.87 Mn |
| Dec 31, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -1.85 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -101,593.00 |
| Sep 30, 2021 | -541,113.00 |
| Jun 30, 2021 | -1.10 Mn |